Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries. Stent Restenosis Study (STRESS) Investigators

• Published in: Journal of the American College of Cardiology Vol. 31; no. 2; pp. 307 - 311
• Main Authors: Savage, M P, Fischman, D L, Rake, R, Leon, M B, Schatz, R A, Penn, I, Nobuyoshi, M, Moses, J, Hirshfeld, J, Heuser, R, Baim, D, Cleman, M, Brinker, J, Gebhardt, S, Goldberg, S
• Format: Journal Article
• Language: English
• Published: United States 01-02-1998
• Subjects: Angioplasty, Balloon, Coronary; Chi-Square Distribution; Cohort Studies; Coronary Angiography; Coronary Disease - diagnostic imaging; Coronary Disease - pathology; Coronary Disease - therapy; Coronary Vessels - pathology; Disease-Free Survival; Elective Surgical Procedures; Equipment Design; Female; Follow-Up Studies; Humans; Linear Models; Male; Middle Aged; Recurrence; Stents; Survival Rate; Treatment Outcome; United States; United States Food and Drug Administration
• ISSN: 0735-1097

The goal of this study was to compare the efficacy of elective stent implantation and balloon angioplasty for new lesions in small coronary arteries.
Palmaz-Schatz stents have been designed and approved by the Food and Drug Administration for use in coronary arteries with diameters > or = 3.0 mm. The efficacy of elective stent placement in smaller vessels has not been determined.
By quantitative coronary angiography, 331 patients in the Stent Restenosis Study (STRESS) I-II were determined to have a reference vessel < 3.0 mm in diameter. Of these, 163 patients were randomly assigned to stenting (mean diameter 2.69 +/- 0.21 mm), and 168 patients were assigned to angioplasty (mean diameter 2.64 +/- 0.24 mm). The primary end point was restenosis, defined as > or = 50% diameter stenosis at 6-month follow-up angiography. Clinical event rates at 1 year were assessed.
Baseline clinical and angiographic characteristics were similar in the two groups. Procedural success was achieved in 100% of patients assigned to stenting and in 92% of patients assigned to angioplasty (p < 0.001). Abrupt closure within 30 days occurred in 3.6% of patients in both groups. Compared with angioplasty, stenting conferred a significantly larger postprocedural lumen diameter (2.26 vs. 1.80 mm, p < 0.001) and a larger lumen at 6 months (1.54 vs. 1.27 mm, p < 0.001). Restenosis (> or = 50% diameter stenosis at follow-up) occurred in 34% of patients assigned to stenting and in 55% of patients assigned to angioplasty (p < 0.001). At 1 year, event-free survival was achieved in 78% of the stent group and in 67% of the angioplasty group (p = 0.019).
These findings suggest that elective stent placement provides superior angiographic and clinical outcomes than balloon angioplasty in vessels slightly smaller than 3 mm.